Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis.

CD4 T cells are important in the protective immune response against tuberculosis. Two mouse models deficient in CD4 T cells were used to examine the mechanism by which these cells participate in protection against Mycobacterium tuberculosis challenge. Transgenic mice deficient in either MHC class II or CD4 molecules demonstrated increased susceptibility to M. tuberculosis, compared with wild-type mice. MHC class II-/- mice were more susceptible than CD4-/- mice, as measured by survival following M. tuberculosis challenge, but the relative resistance of CD4-/- mice did not appear to be due to increased numbers of CD4-8- (double-negative) T cells. Analysis of in vivo IFN-gamma production in the lungs of infected mice revealed that both mutant mouse strains were only transiently impaired in their ability to produce IFN-gamma following infection. At 2 wk postinfection, IFN-gamma production, assessed by RT-PCR and intracellular cytokine staining, in the mutant mice was reduced by >50% compared with that in wild-type mice. However, by 4 wk postinfection, both mutant and wild-type mice had similar levels of IFN-gamma mRNA and protein production. In CD4 T cell-deficient mice, IFN-gamma production was due to CD8 T cells. Thus, the importance of IFN-gamma production by CD4 T cells appears to be early in infection, lending support to the hypothesis that early events in M. tuberculosis infection are crucial determinants of the course of infection.

[1]  Polly Matzinger,et al.  A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell , 1998, Nature.

[2]  Stephen P. Schoenberger,et al.  T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.

[3]  Richard A. Flavell,et al.  Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.

[4]  F. Deist,et al.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.

[5]  J. Casanova,et al.  Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. , 1998, Science.

[6]  S. Reed,et al.  Characterization of Human CD8+ T Cells Reactive with Mycobacterium tuberculosis–infected Antigen-presenting Cells , 1998, The Journal of experimental medicine.

[7]  J. Ho,et al.  Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes. , 1998, Journal of immunology.

[8]  J. Flynn,et al.  Effects of aminoguanidine on latent murine tuberculosis. , 1998, Journal of immunology.

[9]  K. Lukacs,et al.  Protection against Mycobacterium tuberculosisInfection by CD8+ T Cells Requires the Production of Gamma Interferon , 1998, Infection and Immunity.

[10]  H. Dockrell,et al.  Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Sette,et al.  Differential effects of cytolytic T cell subsets on intracellular infection. , 1997, Science.

[12]  J. Mudgett,et al.  Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Z. Toossi,et al.  In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Newport,et al.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. , 1996, The New England journal of medicine.

[15]  M. Newport,et al.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.

[16]  A. Apt,et al.  Influence of the mouse BcgTbc‐1 and xid genes on resistance and immune responses to tuberculosis infection and efficacy of bacille Calmette–Guérin (BCG) vaccination , 1996, Clinical and experimental immunology.

[17]  P. Doherty,et al.  Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-2lAb gene. , 1995, Journal of immunology.

[18]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[19]  X. Mo,et al.  Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins , 1995, Journal of virology.

[20]  K. Tanaka,et al.  Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis , 1995, Infection and immunity.

[21]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[22]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[23]  D B Corry,et al.  Constructing polycompetitor cDNAs for quantitative PCR. , 1993, Journal of immunological methods.

[24]  R. Locksley,et al.  Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. , 1993, Science.

[25]  C. Benoist,et al.  Environmental modulation of the autonomy of cytotoxic T lymphocytes , 1993, European journal of immunology.

[26]  J. Abrams,et al.  Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. , 1993, Journal of immunology.

[27]  I. Orme,et al.  T cell response to Mycobacterium tuberculosis. , 1993, The Journal of infectious diseases.

[28]  J. Blackwell,et al.  Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. , 1993, Journal of immunology.

[29]  J. Flynn,et al.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Christopher J. L. Murray,et al.  Tuberculosis: Commentary on a Reemergent Killer , 1992, Science.

[31]  B. Bloom,et al.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.

[32]  W. Roper,et al.  The new tuberculosis. , 1992, The New England journal of medicine.

[33]  C. Flory,et al.  Effects of in vivo T lymphocyte subset depletion on mycobacterial infections in mice , 1992, Journal of leukocyte biology.

[34]  S. Furney,et al.  T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. , 1992, Journal of immunology.

[35]  M. Schilham,et al.  Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4 , 1991, Nature.

[36]  D. Gray,et al.  Mice lacking MHC class II molecules , 1991, Cell.

[37]  W. Boom,et al.  Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes , 1991, Infection and immunity.

[38]  D. Snider,et al.  Tuberculosis in patients with human immunodeficiency virus infection. , 1991, The New England journal of medicine.

[39]  Graham,et al.  T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis , 1989, Infection and immunity.

[40]  I. Orme Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. , 1988, Journal of immunology.

[41]  I. Orme,et al.  Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. , 1984, Cellular immunology.

[42]  S. Kaufmann,et al.  Immune Mechanisms of Protection , 1994 .

[43]  B. Bloom,et al.  Tuberculosis Pathogenesis, Protection, and Control , 1994 .

[44]  M. Denis Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. , 1991, Cellular immunology.